All Rankings

Top 100 Biotech Companies 2026

Private biotechnology and genomics companies, ranked by disclosed lifetime funding.

Known total funding for 100 of 100 ranked companies: $65.6B.

Showing top 100 matching companies · Ranked by total funding raised · Latest company record update Oct 3, 2026

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

76
Terremoto Biosciences

Clinical-stage biotech company using covalent chemistry to develop small molecule medicines for o...

South San Francisco, United States51–200Biotech
Series CTotal funding$358.0MJan 2025
77
Inari Agriculture

AgTech company using AI-enabled predictive design and multiplex gene editing to create superior s...

Cambridge, United States201–500Biotech
Series G+Total funding$357.0MJan 2024
78
BE Biopharma

Biotech company pioneering Engineered B Cell Medicines (BCMs) to treat genetic diseases like Hemo...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$356.0MJan 2025
79
Inscripta

Inscripta is now part of Manus, combining its work with Manus to accelerate the transition to Bio...

Boulder, United States51–200Biotech
Growth EquityTotal funding$353.5MApr 2021
80
Nature's Fynd

Nature's Fynd makes nutritious fungi-based meat and dairy alternatives using Fy protein, born fro...

San Francisco, United States51–200consumer packaged goods, Biotech
Series CTotal funding$350.0MJul 2021
81
Nephron Pharmaceuticals

Nephron Pharmaceuticals manufactures sterile respiratory, ophthalmic, and compounded medications ...

West Columbia, United States501–1000Biotech, Healthcare
Venture RoundTotal funding$350.0MAug 2023
82
Hemab Therapeutics

Hemab develops targeted therapies designed to prevent and treat serious bleeding and thrombotic d...

Cambridge11–50Biotech, Healthcare
Series CTotal funding$347.0MMar 2026
83
Remilk

Remilk uses precision fermentation to produce dairy-identical milk proteins for animal-free dairy...

Rehovot, Israel51–200Food Tech, Biotech
Venture RoundTotal funding$346.3MMay 2026
84
Dewpoint Therapeutics

Biotech company applying biomolecular condensate science to drug discovery across oncology, neuro...

Boston, United States51–200Life Sciences, Biotech
Series DTotal funding$346.1MSep 2025
85
Avistone Pharmaceuticals

Clinical-stage precision oncology company developing innovative targeted therapies for cancer pat...

Beijing, China51–200Biotech, Healthcare
Series BTotal funding$340.0MJan 2024
86
Aspen Neuroscience

Biotech company developing the first autologous iPSC-derived neuron replacement cell therapy for ...

San Diego, United States51–200Biotech, Healthcare
Series CTotal funding$339.0MNov 2025
87
Agomab Therapeutics

Agomab Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserv...

Antwerp, Belgium11–50Biotech, Healthcare
Series DTotal funding$337.8MJan 2024
88
Crystalys Therapeutics

Clinical-stage biopharmaceutical company focused on advancing innovative therapies to address the...

San Diego, United States11–50Biotech, Healthcare
Series BTotal funding$335.0MJul 2026
89
ProFound Therapeutics

Biotech company pioneering discovery of an expanded human proteome to develop new medicines for c...

United States11–50Biotech
Series BTotal funding$333.0MMay 2026
90
Obsidian Therapeutics

Biotechnology company developing engineered tumor-infiltrating lymphocyte cell therapies to impro...

Cambridge, United States51–200Biotech
Series CTotal funding$325.0MApr 2024
91
Synchron

Synchron develops minimally invasive brain-computer interfaces that help people with paralysis co...

New York, United States51–200Biotech, Hardware
Series DTotal funding$325.0MNov 2025
92
Eat Just

Eat Just makes plant-based egg products designed to deliver familiar egg cooking experiences whil...

Alameda, United States201–500Biotech, Food Tech
Venture RoundTotal funding$321.7MSep 2023
93
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series BTotal funding$321.0MNov 2025
94
Noema Pharma

Clinical-stage biotech developing oral small molecule therapeutics for debilitating CNS disorders...

Basel, Switzerland11–50Biotech
Extension RoundTotal funding$318.0MDec 2024
95
Ohalo Genetics

Ohalo Genetics develops advanced breeding systems and improved plant varieties that help farmers ...

South San Francisco, United States51–200Agtech, Biotech
Series CTotal funding$317.3MFeb 2025
96
eGenesis

eGenesis engineers human-compatible donor organs using multiplex gene editing to advance cross-sp...

Cambridge, United States51–200Biotech, Healthcare
Series DTotal funding$316.0MSep 2024
97
Remix Therapeutics

Clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing.

Watertown, United States51–200Biotech
Venture RoundTotal funding$311.0MJun 2026
98
CARGO Therapeutics

Clinical-stage biotech engineering best-in-class CAR T-cell therapies to overcome resistance to c...

San Carlos, United States51–200Biotech, Healthcare
Private EquityTotal funding$310.0MMay 2024
99
Neuron23

Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...

South San Francisco, United States11–50Biotech, Drug Discovery
Series DTotal funding$310.0MJun 2025
100
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series CTotal funding$304.5MMar 2025